Hypoventilation syndrome

Hypoventilation syndrome is a condition characterized by insufficient ventilation to maintain normal blood gas levels, leading to elevated carbon dioxide (hypercapnia) and reduced oxygen (hypoxemia). It can occur due to primary respiratory muscle weakness, central nervous system dysfunction, obesity-related hypoventilation, or chronic lung diseases. Patients often present with daytime sleepiness, morning headaches, fatigue, dyspnea, and in severe cases, cognitive impairment or right heart strain. Early recognition is crucial, as prolonged hypercapnia and hypoxemia can contribute to pulmonary hypertension, heart failure, and multi-organ dysfunction. Diagnosis relies on arterial blood gas analysis, overnight polysomnography, pulmonary function testing, and assessment of underlying causes.

Management of hypoventilation syndrome aims to restore adequate ventilation, correct blood gas abnormalities, and prevent complications. Non-invasive positive pressure ventilation, including bilevel positive airway pressure (BiPAP), is frequently used to support alveolar ventilation, particularly during sleep. In patients with obesity-related or neuromuscular causes, individualized ventilatory settings optimize oxygenation and carbon dioxide elimination. Adjunctive therapies include weight management, treatment of underlying lung disease, and careful monitoring of comorbidities such as cardiovascular disease. Patient education on adherence to therapy, monitoring for symptoms of decompensation, and regular follow-up are essential for long-term success. Multidisciplinary care involving pulmonologists, sleep specialists, nutritionists, and respiratory therapists enhances treatment efficacy. Through comprehensive management, hypoventilation syndrome patients can achieve improved gas exchange, reduced symptoms, and better overall quality of life.